首页 › 基金 › Opus Capital Group, LLC › SLS
Opus Capital Group, LLC 对 SLS 的持仓历史
SELLAS LIFE SCIENCES GROUP I · 医疗保健
Opus Capital Group, LLC 在 Q3 2026 的 13F 申报中披露持有 SLS(SELLAS LIFE SCIENCES GROUP I)403,635 股,市值约 US$5.0M,约占其申报组合的 0.49%,在其申报持仓中市值排名第 34 位。 Opus Capital Group, LLC 最近 13 个申报季度中有 13 个季度披露了 SLS 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Opus Capital Group, LLC 对 SLS 的持仓演变
Opus Capital Group, LLC 于 Q3 2023 首次披露 SLS 持仓:34,500 股(约 US$57K)。 该持仓在 Q2 2026 达到峰值 385,604 股,市值约 US$5.7M。 在 13 次申报中,Opus Capital Group, LLC 10 次增持、0 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 403,635 股、市值约 US$5.0M,环比增持 18,031 股。。 持仓曾出现大幅变动:Q4 2023 增持约 291% (随后一个季度股价下跌 5%)、Q1 2024 增持约 49% (随后一个季度股价上涨 18%)、Q4 2025 增持约 27% (随后一个季度股价上涨 12%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 34.50K | $57.00K | 新进 |
| Q4 2023 | 135.00K | $143.00K | 增持 |
| Q1 2024 | 200.60K | $203.00K | 增持 |
| Q2 2024 | 221.00K | $263.00K | 增持 |
| Q3 2024 | 226.10K | $283.00K | 增持 |
| Q4 2024 | 238.50K | $248.00K | 增持 |
| Q1 2025 | 239.50K | $259.00K | 持有 |
| Q2 2025 | 240.00K | $526.00K | 持有 |
| Q3 2025 | 250.00K | $403.00K | 增持 |
| Q4 2025 | 317.10K | $1.20M | 增持 |
| Q1 2026 | 346.45K | $1.47M | 增持 |
| Q2 2026 | 385.60K | $5.69M | 增持 |
| Q3 2026 | 403.63K | $4.97M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 SLS 与 13F 数据
SLS(SELLAS LIFE SCIENCES GROUP I)属于医疗保健行业。我们追踪的基金中还有 106 只申报持有 SLS,申报仓位最大的包括:Sio Capital Management, LLC (US$18.2M), DAGCO, INC. (US$16.5M), Anson Funds Management LP (US$11.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 SLS 的基金
- Sio Capital Management, LLC 1.23M 股 · $18.17M · Q2 2026
- DAGCO, INC. 1.34M 股 · $16.45M · Q3 2026
- Anson Funds Management LP 800.00K 股 · $11.81M · Q2 2026
- Ikarian Capital, LLC 354.70K 股 · $5.24M · Q2 2026
- Rosalind Advisors, Inc. 568.70K 股 · $2.30M · Q2 2026
- FULCRUM WEALTH ADVISORS, LLC 85.45K 股 · $1.05M · Q3 2026
- VISION FINANCIAL MARKETS LLC 57.00K 股 · $701.67K · Q3 2026
- Marathon Trading Investment Management LLC 50.10K 股 · $616.73K · Q3 2026
- INSTRUMENTAL WEALTH, LLC 44.91K 股 · $552.89K · Q3 2026
更多关于 Opus Capital Group, LLC
常见问题
How long has Opus Capital Group, LLC held SLS?
Opus Capital Group, LLC has disclosed SLS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Opus Capital Group, LLC's current position in SLS?
As of Q3 2026, Opus Capital Group, LLC holds 403.63K shares of SLS (SELLAS LIFE SCIENCES GROUP I), valued at $4.97M, representing 0.49% of its reported portfolio and ranking #34.
Has Opus Capital Group, LLC been buying or selling SLS?
In the latest 13F filing (Q3 2026), Opus Capital Group, LLC increased its position in SLS. The position peaked in Q2 2026 at 385.60K shares.
Which other funds hold SLS?
Other major institutional holders of SLS include Sio Capital Management, LLC, DAGCO, INC., Anson Funds Management LP, among 106 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.